08:42 AM EDT, 08/15/2024 (MT Newswires) -- Haemonetics ( HAE ) said Thursday it has fully released the Vascade MVP XL medical device to the market and it is now available to US hospitals.

MVP XL adds the Haemonetics' ( HAE ) Vascade portfolio of vascular closure devices used in heart ablation, the company said.

The new device launched a limited market release in June and has since been used at over 30 hospitals, Haemonetics ( HAE ) said.

Price: 75.00, Change: +1.82, Percent Change: +2.49